Skip to Content

Par 564 (Lamotrigine Extended-Release 200 mg)

Pill with imprint Par 564 is Yellow, Round and has been identified as Lamotrigine Extended-Release 200 mg. It is supplied by Par Pharmaceutical Inc..

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Par 564

Lamotrigine extended-release 200 mg Par 564
Lamotrigine extended-release 200 mg Par 564 Front
Lamotrigine extended-release 200 mg Par 564 Back
Lamotrigine extended-release 200 mg Par 564
Lamotrigine extended-release 200 mg Par 564

Lamotrigine Extended-Release

Imprint
Par 564
Strength
200 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Inc.
National Drug Code (NDC)
49884-0564

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.